Former Sen. Ben Sasse, 54, called daraxonrasib "a miracle drug" that was allowing him to live longer and with less pain.
The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other ...
Applied BioCode, a leader in multiplex molecular diagnostic solutions, today announced a significant enhancement to its ...
Second Nature Brands has issued a recall of its Keto Crunch Smart Mix on Friday after discovering the product may contain ...
The FDA said the action recognizes the dire need for a drug to improve survival for pancreatic cancer patients, who face the ...
A federal appeals court temporarily reinstated a nationwide requirement that abortion pills be obtained in person, ...
The Food and Drug Administration proposed excluding Novo Nordisk and Eli Lilly's weight-loss drugs from a key compounding ...
The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreatic cancer drug ...
The Food and Drug Administration (FDA) has named Katherine Szarama to be the acting director of the unit in charge of ...
Looking to clarify its expectations on manufacturer responses following inspections, the FDA earlier this year unveiled, for ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...
Multiple drugs used to treat patients in hospital and clinical settings nationwide are being recalled because they did not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results